Elodie Charbaut Taland Merck

Elodie Charbaut Taland

Elodie Charbaut Taland Merck Global Regulatory Affairs

Elodie Charbaut Taland works as Associate Director in Merck KGaA GRA CMC Regulatory Intelligence team. She has 15 years of experience in biological drug substance process development and manufacturing, covering development products, marketed products, and biosimilars. She is now involved in CMC regulatory intelligence activities, with a focus on advocacy for the introduction of innovative technologies. In this context, she is co-leading the elaboration of the EFPIA position paper on the use of Next Generation Sequencing for virus safety testing. Elodie Charbaut Taland holds an Engineering degree from Ecole Polytechnique, France, and a PhD in Neurosciences from the University Pierre et Marie Curie, France.